Nasogastric and Orogastric Tube Insertion and Management



  • Introduction

    A wide range of infants and children may require a nasogastric (NGT) or orogastric (OGT) tube.  It is imperative that nursing staff caring for patients who have enteral tubes understand why it is in-situ. These tubes may be used to:

    • Administer bolus, intermittent and/or continuous enteral nutrition
    • Administer Medication
    • Facilitate free drainage and/or aspiration of the stomach contents
    • Facilitate venting/decompression of the stomach
    • Stent the oesophagus*

    *This guideline does not refer to the care of trans-anastomotic tube (TAT), these remain in-situ post-operatively and should only be removed or replaced following medical clearance. If the TAT is dislodged inadvertently, immediately notify the neonatal and/or surgical teams. Feeds and medications should only be administered via a TAT tube at the direction of the treating medical team. 

    This guideline aims to support nurses in inserting and managing nasogastric (NGT) or orogastric tubes (OGT) and is intended to be used in conjunction with clinical judgement and the needs of individual patients.

    Note the scope of this guideline does not include jejunal tubes or gastrostomy tubes. For information regarding care of these tubes see the RCH Nursing Guideline: Jejunal Feeding, RCH Nursing Guideline: Enteral feeding and medication administration and the RCH Nursing Guideline: Gastrostomy.

    Definition of Terms

    • Continuous Positive Airway Pressure (CPAP): a type of positive airway pressure to deliver a set positive end expiratory pressure to the airway, maintained throughout the respiratory cycle.
    • Nasal Retention Device (NRT): AMT Bridle™ see appendix
    • Nasogastric tube (NGT): Thin, soft tube passed through a child’s nose, down the back of the throat, through the oesophagus and into the stomach.
    • NEMU method: NGT tube placement measurement taken from nose to ear lobe to the point midway between the xiphisternum and the umbilicus 
    • Neonate: an infant that is up to 28 days of age corrected post term (e.g. an infant born at 34 weeks gestation and is 8 weeks old is 14 days corrected post term) 
    • Orogastric tube (OGT): Thin, soft tube passed through a child’s mouth, through the oropharynx, through the oesophagus and into the stomach
    • pH value: describes how acidic or basic an aqueous solution is.  pH below 7 is acidic and a pH greater than 7 is basic. Gastric pH values are usually between 1-5.0

    Assessment

    Prior to commencing enteral feeding, the treating team must determine the safest route and site for enteral feeding.

    Indications for NGT/OGT

    An enteral feeding tube should be considered where a patient has unsafe or inadequate oral intake to meet nutritional requirements.

    Indications may include:

    • Congenital anomalies
    • Eating disorders
    • Facial, oropharyngeal and/or oesophageal structural abnormalities
    • Increased nutritional requirements e.g. in Cystic Fibrosis, burns, oncology diagnosis
    • Impaired oral feeding and swallowing e.g. prematurity, trauma

    Enteral feeding tubes can also be used to:

    • Prevent / reverse malnutrition related to chronic illness or recovery from trauma
    • Optimise recovery post-surgery
    • Facilitate venting and decompression of the stomach
    • Prevent deterioration in quality of life

    Additional enteral tubes can also be used for:

    • Administering medications
    • Gastro-intestinal de-compression and/or drainage

    Contraindications for NGT/OGT

    Absolute contraindications

    • Gut failure (for feeding)
    • Inability to gain safe enteral access ie significant mid face trauma, basal skull fracture (for NGT)

    Relative contraindications

    • Coagulation abnormalities
    • Oesophageal trauma i.e. recent alkaline ingestion (due to risk of oesophageal rupture)
    • Oesophageal varices (untreated or recently banded/cauterised)
    • Oesophageal strictures including history of recent oesophageal surgery
    • Oesophageal obstruction due to neoplasm or foreign body
    • History of recent gastric perforation or gastric surgery
    • Recent nasal surgery

    In the presence of relative contraindications, the advantages and disadvantages of tube placement will need to be considered and discussed with the treating team and senior nursing staff in clinical area This responsibility remains with the treating team.

    Special Considerations

    Various aspects may hamper the ability to accurately and safely insert a NGT/OGT.  In the following clinical situations, only a skilled senior clinician should attempt insertion:

    • Mucositis
    • Low platelet count (remove stylet prior to insertion)
    • Repeated insertions of NGTs more than 2 unsuccessful attempts
    • Inability to swallow on command
    • Impaired cough/gag reflex
    • Intubation (current or recent)
    • Tracheostomy
    • Anatomical abnormalities
    • Critical illness
    • Liver disease and or portal hypertension
    • Known or suspected oesophageal varices
    • Previous gastric bypass surgery, hernia repair, or abnormal GI anatomy - tubes should be placed under endoscopy.
    • If the child has procedural anxiety and child is unlikely to tolerate procedure, consider an EMR referral to Child Life Therapy or Comfort Kids or Comfort First for procedural support.

    Selecting the correct NGT/OGT

    • The smallest size possible should be used to accommodate feed consistency, gastric drainage and patient comfort. Tube size will vary with the size of the child and the rationale for insertion.
    • If the purpose of the tube is decompression or drainage a larger size short term tube with radio opaque marker is appropriate. When enteral feeding commences, the tube should be changed to one with a smaller lumen size as soon as practical.

    Tube considerations for neonates

    • Neonates are obligatory nose breathers and the presence of a NGT may increase airway resistance.
    • OGTs may be considered in:
      • very low birth weight neonates less than 1500g  
      • neonates that have respiratory distress needing midline CPAP or nasal cannula for oxygen delivery. 
      • structural or anatomical abnormality (e.g. choanal atresia, cleft lip/palate)  
      • nasal trauma. 

    Tube considerations for infants and older children

    • In general, a tube size of 6fr-10fr should be used. 
    • Larger sizes (over 10fr) may be used on children over 12 years based on clinical judgement. 


    Table 1: Tube details

    Tube Material Use Size Availability Frequency of Change Please note
    Poly vinyl chloride (PVC)  Neonates, infants and children who require short term tube feeds, treatment or decompression of the stomach 6fr, 8fr 10fr, 12fr, 14fr, 16fr, 18fr

    Short term

    Refer to manufacturer’s guideline on packaging for recommended length of time between tube changes.

    If not specified, suggest maximum dwell time of 4 weeks.

    Polyurethane (PU)

    Neonates, infants and children who require long term tube feeds or treatment.

    Preferred tube in children with liver disease, portal hypertension and oesophageal varices regardless of the length of time the tube is used for. 

    6fr, 8fr, 10fr, 12fr

    Long term

    Refer to manufacturer’s guideline on packaging for recommended length of time between tube changes.

    If not specified, suggest maximum dwell time of 8 weeks.

    Polyurethane tubes in patients less than 1 year of age or who are immunocompromised are recommended to be changed 4 weeks. 

    May include a stylet which should be removed after the tube is inserted.

    Remove stylet prior to insertion for all liver disease, portal hypertension and oesophageal varices.

    If a stylet is not used for insertion (refer to considerations) the tube may be placed in the freezer prior to insertion in order to reduce pliability of the tube.

    Preparing for NGT/OGT insertion

    • The treating team places an EMR order for initial insertion of the NGT/OGT
    • Prepare the patient and family for the insertion of the tube by providing an age-appropriate explanation of the procedure and explaining the reasons for necessity. The patients and family have received information relating to the intended procedure and given appropriate consent. 
    • Inserting a NGT/OGT tube can be an uncomfortable and/or painful procedure therefore consideration should be given to the use of procedural pain management and/or sedation.
    • Consider and plan for age-appropriate procedural holding and non-pharmacological distraction techniques
    • Consider using sucrose for infants up to 12 months if appropriate
    • Consider using topical anaesthetic nasal spray (co-phenylcaine) in older children (over 2years) if appropriate. 
    • For further information please see the Procedure Management Guideline.

    Equipment required

    • Suction and oxygen should be available in hospital setting
    • Appropriate type and size of tube
    • Lubrication - Water or water-based lubricant OR use patient’s own saliva (neonates)
    • pH test indicators
    • 5-10ml enteral syringe for aspiration 
    • Marker or Tape for securement of NGT/OGT
    • Appropriate Personal Protective Equipment (PPE) for standard precautions such as gloves.

    Procedure

    1. Assessment of nasal passage 
      a) It is recommended that the nostrils and/or oral cavity be assessed to identify any possible abnormalities or obstructions prior to insertion of the tube. If reinserting a tube, consider alternating nostrils if possible.  
    2. Determining the length of the tube to placed
      a) Ensure distal end measurement (i.e. the part of the tube that will sit in the stomach) is to the exit port of the tube. The exit port may not be at the tip of the tube; it may be approximately 5-20mm from the actual tip of the tube.  
      b) NEMU (Nose, Ear, Mid Umbilicus) method:  With head in the midline, measure the length of the tube to be inserted by placing the exit port of the tube at the tip of the nose (NGT) or corner of the mouth (OGT), and by measuring the length to the ear lobe, then to the point midway between the xiphisternum and the umbilicus.  
      c)Mark this point on the tube with marker or small piece of tape.  
    3. Positioning the Patient
      a) Neonate: Place neonate in supine position with the head in the midline. Swaddle limbs to contain activity.  Administer sucrose or initiate non-nutritive sucking with a dummy, which often helps to facilitate the advancement of the tube. 
      b) Infant and Child: The child needs to be positioned/supported in a manner that prevents hyperextension of the neck.    Where possible allow child to sit up, without any head tilt (chin up). Maintaining the child's head tilted slightly forward will assist in closing the epiglottis and open the oesophagus. This is of relevance to children, as they are often positioned lying down for the procedure, and when distressed children will arch their back resulting in throwing their head back. Therefore, the person assisting may need to have a hand under the child's head to maintain it in the forward position.
      c) Procedural positioning for both infant and child can be found on the Comfort Kids website. Please see the Procedural Management guideline for further information  
    4. Lubricating the tube
      a) The purpose of lubrication is to aid the passing of the tube and reduce patient discomfort. Water or a water-based lubricant is recommended, or in neonates use their own saliva. Never use oil-based lubricant as this can result in aspiration pneumonia if the patient inhales during insertion. 
      b) The Nasogastric Tube may require lubricating internally by flushing 2-3mls of water prior to insertion. 
    5. Insertion of tube
      a) NGT: Insert the tube into patent nostril, gently aiming posterior and parallel to the nasal septum then aim downward. Ask the child to swallow or waiting for a swallow to occur can assist in passing the tube. With a neonate or infant (who would normally use a dummy) the use of a dummy can assist the passing of the tube by causing a suck/swallow reflex. Insert tube to the pre-measured length.
      b) OGT: Insert the tube into the oral cavity over the tongue. Aim the tube posterior and downward through the oropharynx to the pre-measured length. 
      c) If resistance is met during insertion with either tube, stop advancement and adjust direction slightly before reattempting. 
      d) During insertion of the tube, monitor for respiratory distress, excessive coughing or choking.  
             i) If this occurs, stop advancing the tube and observe inside the oral cavity as the tube may be coiled at the back of the throat. 
            ii) If it is, withdraw the tube slightly and reattempt.
           iii) It may be necessary to let the child rest, then continue to advance the tube slowly until the desired length has been passed. For neonates, remove tube completely, resettle the patient, and start again.
           iv) Note the patient may not have signs of respiratory distress when the tube is accidentally placed in the airway, especially if the patient has an impaired level of consciousness.
      *Please note for patients with known or suspected Oesophageal Varies the stylet should be removed prior to inserting NGT
    6. Securing tube for use 
      a) Securement of the tube is recommended after position of tube has been confirmed however may be necessary prior to confirmation of position, particularly if the child is distressed.
      b) Current securement method recommended is Comfeel® taped to the cheek, followed by Hypafix®, Mefix ® or Tegaderm™, positioned over the tube to secure it in place. Ensure the tube is positioned so as not to place pressure on the nares and to reduce the risk of a pressure injury
      c) Document the centimetre marking on the tube, where it exits the nose or mouth
      d) Remove stylet prior to accessing tube.  
    7. Confirm placement prior to accessing tube
      a) Observe for a change in the marked reading of the tube at the lip/nares or change in length of external portion of the tube 
      b) Obtain gastric aspirate pH 1-5.0 (refer below)

    Post Procedure

    • Observe for signs of respiratory distress e.g. persistent coughing and gagging, and cyanosis, desaturations (if monitored).
    • Document tube insertion into EMR under LDAs.

    Obtaining gastric aspirate

    Equipment

    • pH test indicators
    • 5-10ml enteral syringe for aspiration
    • Appropriate PPE; Nonsterile gloves

    Procedure

    • The 5 moments of hand hygiene must be practiced before, during, and after this procedure
    • Attach enteral syringe. Slowly and gently aspirate about 2.5 ml of fluid, (this makes sure the fluid is coming from the stomach, and not just from inside the tube).
    • Apply gastric content to pH test strip and assess pH level  

    Table 2 Trouble shooting

    Potential Problem

    Risk factors/Common causes

    Action

    Prevention

    Aspirate pH >5.0

    Acid suppression medications may affect gastric pH.

    Classes of medications which increase gastric pH are: 

    • Proton pump inhibitors 
    • Antacids
    • Anticholinergics 
    • H2 antagonists
    • If the patient is receiving a medication which is known to alter pH readings notify medical team, pharmacy and senior nursing staff.
    • A clear plan or acceptable adjusted pH range for confirming the tubes position should be documented in the EMR.
    If possible, pH should be tested just prior to receiving these medications.
    If unable to obtain aspirate 
    • Tube not advanced far enough
    • Tube not positioned in gastric fluid due to patient positioning
    • Turn the patient onto their side as this may allow the tip of the tube to move to a position where fluid has accumulated.
    • If patient able to tolerate oral fluids, offer oral fluids and reattempt aspirate.
    • If unable to offer oral fluids: reattempt after 15-30 minutes to allow time for more gastric contents to accumulate in the stomach.
    • Adjust tube position (advance or pull back tube by 1-2cm) and reattempt aspirate.
    • If using a dual port NGT, ensure second port is tightly sealed.
    • If aspirate not obtained discuss with senior nursing staff or medical staff.
    • Consider removing the tube or checking position by x-ray
    Blocked NGT/OGT
    • Inadequate flushing or poor flushing technique 
    • Interaction between gastric acid, formula and medications
    • Interactions between medications if tube is not flushed between medications 
    • Inappropriately prepared medications e.g., inadequately crushed tablets 
    • Small internal diameter of the tubes and longer tubes 
    • Binding of medication to the tube 
    • Viscosity of some liquid preparation 
    • Bacterial colonization of the nasogastric tube 
    • Flush the tube in a pulsating manner (push -stop, push -stop) with warm water, if it is safe to do so considering the child’s age, size and clinical status. Suggested 3-5ml for Neonates or 5-10ml for paediatric patients unless otherwise indicated by treating team.
    • It may be appropriate to allow the warm water to soak, by clamping/capping the tube, to assist with unblocking. 
    Please note there is no evidence to support the practice of using carbonated or acidic such as Coca Cola™ to unblock enteral tubes. 

    Flushing is the single most effective action that prolongs the life of nasogastric tubes.

    It is recommended that flushing occur BEFORE, DURING and AFTER administration of enteral medications and feeds.

    Suggested 3-5ml for Neonates or 5-10ml for paediatric patients unless otherwise indicated by treating team.

    Dislodgement or accidental removal of NGT/OGT

    Poor securement

    Child pulling at NGT/OGT

    • Dislodgement – stop feed/medication immediately. Consider if NGT can be repositioned or if it needs to be removed. Do not use NGT/OGT until correct position is confirmed.
    • Decision to reinsert should consider ongoing nutritional needs and clinical status of the child and be made in consultation with senior nursing staff, medical team and/or dietician.

    Use of appropriate securement device.

    Regular assessment of securement device.

    Pressure Injury

    NGT/OGT placing pressure on nares and/or face.

    Poor securement

    See Pressure injury and prevention guideline Use of appropriate securement device Regular assessment of securement device.

    Special considerations

    Patients with known/suspected oesophageal varices see the Acute management of an oesophageal variceal bleed guideline for further information.

    Patients with liver disease, portal hypertension, known or suspected presence of portal gastropathy.

    Please discuss with the gastro, treating team and senior nursing staff regarding the risk/benefits associated with tube changes, and troubleshooting gastric aspirates in these patient groups.

    • NGT and OGTs can cause direct trauma to the stomach lining (for all types of patients)
    • Aspiration should always be slow and gentle 
    • Avoid frequent NG replacement due to the risk of local trauma and subsequent bleeding.  

    Please discuss with the gastro, treating team and senior nursing staff regarding the risk/benefits associated with tube changes, and troubleshooting gastric aspirates in these patient groups.

    Verification of tube placement

    There is potential risk for NGT misplacement with each insertion. A misplaced NGT compromises patient safety, increasing the risk for serious and even fatal complications. There is no standardised method for verification of the initial NGT placement or reverification assessment of NGT location prior to use.

    • X-ray is considered the gold standard to verify NGT location. Cumulative radiation exposure related to radiographs in paediatric patients is a concern and is not a practical method to verify tube placement or position for every patient prior to every feed or administration of medication.
    • Measurement of the acidity or pH of the gastric aspirate is the most frequently used evidence-based method to verify NGT placement.
    • Auscultation is not a reliable method for checking tube placement and should be avoided.
    • Assessment of external tube position and a gastric aspirate should be sufficient to confirm tube placement for most patients. 
    • An x-ray may be used to confirm placement if concerns remain or position can’t be confirmed via other methods.

    The position of the tube must be confirmed in the following situations:

    • When a new tube is inserted
    • Before each use of the tube for feeds, water and/or medications.
    • When there is concern that the tube may have been pulled out of changed position (ie markings have changed, taping has come loose etc)
    • Changes in clinical condition that may indicate tube displacement – examples may include, but not limited to:
    • For continuous feeds, verify external markings and confirm pH every 4 hours, at change of feed bottle or medication administration (whichever is shorter).

    Special considerations

    Consider an x-ray for any patient in whom there is any concern for correct NGT placement, such as:

    • Difficulty placing the NGT
    • NGT placement in any patient at high risk of misplacement.  Example: known history of facial fractures, neurologic injury/insult/baseline abnormality, respiratory concerns, decreased or absent gag reflex, and those who are critically ill.
    • In any patient whose condition deteriorates shortly after NGT placement

    Changing, reinserting or removal of an NGT/OGT

    • Frequency of tube change may vary depending on material of the tube. Refer to manufacturer’s guideline on packaging for recommended length of time between tube changes.  
    • In absence of manufacturer’s advice all PVC tubes should be routinely changed every 4 weeks and polyurethane tubes, changed every 8 weeks. 
    • The medical team who has ordered the NGT/OGT to be placed is responsible for informing the family when a tube should be changed if inserted for long term use, the plan should be documented in the EMR.
    • Tubes may be changed more frequently if evidence of skin compromise, frequent tube occlusion or clinical judgement.
    • Care should be taken to prevent skin injury when removing adhesive tapes securing tube - consider use of protective barrier wipes such as Convacare™.

    Equipment

    • Appropriate PPE; Nonsterile gloves
    • Adhesive remover if required.

    Tube Removal Procedure

    1. The 5 moments of hand hygiene must be practiced before, during, and after this procedure
    2. Turn off suction or continuous feeding, if applicable.
    3. Position the child in the supine position. Elevate the head of the bed as tolerated by the child. Encourage parental presence for support. Prepare the child as per the procedure management guideline.
    4. Gently remove tape from the face. Consider the use of adhesive remover or saline wipe to assist in the removal of tape.
    5. Occlude the tube by pinching it closed, bending it, and holding it with the thumb and index finger. Pull the tube out of the mouth or nose using a swift, consistent motion.


    Evidence Table 

    Reference 

    Source of Evidence

    Key findings and considerations 
    Best, C., (2016). How to insert a nasogastric tube and check gastric position at the Bedside. Nursing Standard. 30, 38, 36-40.  Evidence from a single descriptive or qualitative study

    It is important for Nurses to be able to recognise problems that may arise when inserting NGT blindly, and to know what actions to take if it is suspected that the distal tip is not sitting in the stomach, or they are unable to identify its location 

      Boullata, Joseph I et al. “ASPEN Safe Practices for Enteral Nutrition Therapy JPEN. Journal of parenteral and enteral nutrition vol. 41,1 (2017): 15-103. doi:10.1177/0148607116673053  Expert consensus - Recommendations from authoritative bodies 
      Contraindications to EAD placement 
      Use accurate measurement of enteral tube insertion length, gastric pH testing, and visual observation of gastric aspirate as acceptable nonradiologic methods for assessing tube placement when radiographic verification is not available.   

        Cirgin Ellett, Marsha L et al. “Predicting the insertion length for gastric tube placement in neonates.” Journal of obstetric, gynecologic, and neonatal nursing : JOGNN vol. 40,4 (2011): 412-21. doi:10.1111/j.1552-6909.2011.01255.x
        RCT

        Direct distance nose-ear-xiphoid should no longer be used as an nasogastric/orogastric (NG/OG) tube insertion-length predictor in neonates. Either NEMU for NG/OG tubes or the new ARHB equation for NG tubes should be used.

          Dias FSB, Emidio SCD, Lopes MHBM, Shimo AKK, Beck ARM, Carmona EV. Procedures for measuring and verifying gastric tube placement in newborns: an integrative review. Rev Lat Am Enfermagem. 2017 Jul 10;25:e2908. doi: 10.1590/1518-8345.1841.2908. PMID: 28699995; PMCID: PMC5511002.  Systematic review
          The measuring method using nose to earlobe to a point midway between the xiphoid process and the umbilicus measurement presents the best evidence. Equations based on weight and height need to be experimentally tested. The return of secretion into the tube aspiration, color assessment and secretion pH are reliable indicators to identify gastric tube placement, and are the currently indicated techniques.  

             Fan EMP, Tan SB, Ang SY. Nasogastric tube placement confirmation: where we are and where we should be heading. Proceedings of Singapore Healthcare. 2017;26(3):189-195. doi:10.1177/2010105817705141  Systematic review

            Summary of the different methods of NGT placement confirmation and discusses their advantages and limitations

            • xray is gold standard but not feasible to use for every NGT us
            • pH testing is recommended. pH of 5 or less is reasonable to use as cut off point to determine a gastric placement of NG
            • auscultation with insufflation of air via NGT sounds may be transmitted to the epigastrium whether the tube is positioned in the lung, oesophagus, stomach or jejunum.
            Gilbertson, Heather Ruth et al. “Determination of a practical pH cutoff level for reliable confirmation of nasogastric tube placement.” JPEN. Journal of parenteral and enteral nutrition vol. 35,4 (2011): 540-4. doi:10.1177/0148607110383285  Prospective observational study Lowest pH value of endotracheal aspirate was 6, and a misplaced NG tube was identified with pH 5.5, it is proposed that a gastric aspirate of pH 5 or less is a safer, reliable, and practical cutoff  

               Lord, L (2018). Enteral Access Devices: Types, Function, Care and Challenges. Nutrition in Clinical Practice  Clinical recommendations 

              Function, care, and challenges of enteral access devices

                National Patient Safety Agency Alert. :Reducing the harm caused by misplaced nasogastric feeding tubes in adults, children and infants.  March 2011   National standards

                Xray is gold standard and pH testing is to be used as first line testing method. This article suggests 1-5.5 is acceptable pH. Documentation of the tube placement checking process includes confirmation that any xray viewed was the most current xray for the correct patient and clear instructions as to actions required are provided. Any tubes identified to be in the lung are removed immediately

                  NSW Health Guideline  2023 “Insertion and Management of Nasogastric and Orogastric Tubes in Adults” Insertion and Management of Nasogastric and Orogastric Tubes in Adults (nsw.gov.au)  Clinical guideline

                  Insertion and management of nasogastric and orogastric tubes

                     Pash, E,. (2018). Enteral Nutrition: Options for Short-Term Access. Nutrition in Clinical Practice. 33, 170-176   Expert opinion Enteral Nutrition is preferred to support a functional gastrointestinal tract. 
                    OGT and NGT are preferred as can be placed at bedside and are less invasive than more permanent surgical options. 
                    There is not clear consensus on the exact duration of use for short term enteral access other than the 4-6 week time frame mentioned.   

                      Riccuito,A. Baird, R., & Anna, A., (2015). A retrospective review of Enteral Nutrition Support at a Tertiary Paediatric Hospital: A comparison of prolonged nasogastic and gastrostomy tube feeding. Clinical Nutrition Vol 34, 4 652-658  RCT

                      There is little evidence clarifying best practices pertaining to prolonged NGT and gastrostomy tube use in children. 
                      Median Duration of NGT placement was 7.8 months 
                      Gastric Tube complication rate was almost double that seen with NGT. 

                         Society of Pediatric Nurses (SPN) Clinical Practice Committee et al. “Best evidence: nasogastric tube placement verification.” Journal of pediatric nursing vol. 26,4 (2011): 373-6. doi:10.1016/j.pedn.2011.04.030  Systematic review Auscultation is not a reliable indicator of NGT placement.
                        Gastric pH testing 5 or lower can be correlated with correct placement in the stomach.
                        Visual appearance of gastric secretions is less accurate that pH testing but may be used a secondary confirmation method.
                        Marking the tube after initial verification and measuring the external length may provide secondary confirmation data. This technique has limited value and only provides an estimate as to whether the tube has been dislodged but does not indicate the position of the distal tip.  

                            Yi DY. Enteral Nutrition in Pediatric Patients. Pediatr Gastroenterol Hepatol Nutr. 2018 Jan;21(1):12-19. doi: 10.5223/pghn.2018.21.1.12. Epub 2018 Jan 12. PMID: 29383300; PMCID: PMC5788946.  Expert opinion

                          Indications and contraindications of EN
                          Sites and modes of delivery
                          Complications of EN


                          Please remember to read the disclaimer.


                          The development of this nursing guideline was coordinated by Keryn Coster, Dietitian, Nutrition, Shae Lane, CNS, Specialist Clinics, and Kate Hession, RN, Specialist Clinics, approved by the Nursing Clinical Effectiveness Committee. First published August 2024.